BIIB033
Подписчиков: 0, рейтинг: 0
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Clinical data | |
| Other names | Anti-LINGO-1 |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
BIIB033 (also known as Anti-LINGO-1) is a monoclonal antibody targeting LINGO1. As of 2015 it was being developed by Biogen as a treatment for diseases such as multiple sclerosis and optic neuritis.